Treventis VP Research Dr. Marcia Taylor was an invited speaker at the Targeting Protein Misfolding Summit, held virtually from March 15-17, 2021.
Dr. Taylor presented a talk about our small molecule lead program in tauopathy and Alzheimer’s entitled “Use of in vitro and in vivo models to measure reduction of tau and amyloid beta oligomer.”
This presentation was excellent exposure for the Treventis approach. Dr. Taylor felt it was an excellent opportunity to experience an interesting mix of talks as well as participate in small group discussions with other experts in the industry.